{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:06:40Z","timestamp":1791547600078,"version":"4.3.4"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015539","name":"Commonwealth of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP230100485"],"award-info":[{"award-number":["DP230100485"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtbi.2026.112396","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:26:30Z","timestamp":1770222390000},"page":"112396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Optimising chemotherapy for advanced high-grade serous ovarian cancer via delay-differential equations"],"prefix":"10.1016","volume":"623","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8765-9148","authenticated-orcid":false,"given":"Cristina","family":"Koprinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6093-8769","authenticated-orcid":false,"given":"Georgio","family":"Hawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-4744","authenticated-orcid":false,"given":"Peter S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2026.112396_bib0001","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2026.112396_bib0002","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00262-021-03072-6","article-title":"Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells","volume":"71","author":"Abdullah","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jtbi.2026.112396_bib0003","unstructured":"Anaya, J. M., Shoenfeld, Y., Rojas-Villarraga, A., Levy, R. A., Cervera, R., 2013. Autoimmunity: from bench to bedside. El Rosario University Press."},{"key":"10.1016\/j.jtbi.2026.112396_bib0004","first-page":"409","article-title":"Phase i evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins","year":"1997","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1089\/jir.2012.0087","article-title":"Interferon-\u03b3-induced necrosis: an antitumor biotherapeutic perspective","volume":"33","author":"Balachandran","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2018.01.022","article-title":"Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer","volume":"117","author":"Barua","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1369597","article-title":"Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy","volume":"12","author":"Basar","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0008","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri2379","article-title":"T-cell activation by dendritic cells in the lymph node: lessons from the movies","volume":"8","author":"Bousso","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0009","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3348","article-title":"Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer","volume":"7","author":"Cachot","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jtbi.2026.112396_bib0010","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","article-title":"Carboplatin dosage: prospective evaluation of a simple formula based on renal function","volume":"7","author":"Calvert","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0011","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/0008-5472.CAN-06-2264","article-title":"DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells","volume":"67","author":"Carlsten","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.immuni.2004.08.007","article-title":"Visualizing the first 50\u202fhr of the primary immune response to a soluble antigen","volume":"21","author":"Catron","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jtbi.2026.112396_bib0013","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMoa1505067","article-title":"Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer","volume":"374","author":"Chan","year":"2016","journal-title":"N. N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2026.112396_bib0014","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1002\/cam4.2560","article-title":"Ovarian cancer: current status and strategies for improving therapeutic outcomes","volume":"8","author":"Chandra","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.jtbi.2026.112396_bib0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0016","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.179.8.4969","article-title":"Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 th cells at tumor sites","volume":"179","author":"Chaput","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0017","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.4049\/jimmunol.172.4.2059","article-title":"IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils","volume":"172","author":"Chen","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduction and Targeted Ther."},{"key":"10.1016\/j.jtbi.2026.112396_bib0019","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1359-6101(03)00003-0","article-title":"TGF-\u03b2: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression","volume":"14","author":"Chen","year":"2003","journal-title":"Cytokine; Growth Factor Rev."},{"key":"10.1016\/j.jtbi.2026.112396_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molimm.2018.01.014","article-title":"Molecular regulation of dendritic cell development and function in homeostasis, inflammation, and cancer","volume":"110","author":"Chrisikos","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0021","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148643","article-title":"T cell\u2013derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death","volume":"6","author":"Chun","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtbi.2026.112396_bib0022","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(22)00283-2","article-title":"Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial","volume":"23","author":"Clamp","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0023","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(19)32259-7","article-title":"Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial","volume":"394","author":"Clamp","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jtbi.2026.112396_bib0024","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archotol.128.2.167","article-title":"Analysis of cell-cycle checkpoint pathways in head and neck cancer cell lines","volume":"128","author":"Coleman","year":"2002","journal-title":"Arch. Otolaryngol.\u2013Head; Neck Surg."},{"key":"10.1016\/j.jtbi.2026.112396_bib0025","first-page":"31","article-title":"Interleukin-4 (b-cell stimulatory factor-1) augments the in vivo generation of cytotoxic cells in immunosuppressed animals","volume":"1","author":"Conlon","year":"1989","journal-title":"Biotechnol. Ther."},{"key":"10.1016\/j.jtbi.2026.112396_bib0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-023-06816-9","article-title":"Dictionary of immune responses to cytokines at single-cell resolution","volume":"625","author":"Cui","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jtbi.2026.112396_bib0027","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1063\/1.1680571","article-title":"Study of the sensitivity of coupled reaction systems to uncertainties in rate coefficients. I theory","volume":"59","author":"Cukier","year":"1973","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jtbi.2026.112396_bib0028","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.4049\/jimmunol.171.10.5165","article-title":"CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3\u202fcytokine","volume":"171","author":"Curtsinger","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0029","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4049\/jimmunol.162.6.3256","article-title":"Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells","volume":"162","author":"Curtsinger","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0030","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/embj.201488027","article-title":"Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming","volume":"33","author":"Dalod","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.jtbi.2026.112396_bib0031","doi-asserted-by":"crossref","DOI":"10.1172\/JCI36628","article-title":"Tumor emergence is sensed by self-specific CD44hi memory tregs that create a dominant tolerogenic environment for tumors in mice","author":"Darrasse-J\u00e8ze","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jtbi.2026.112396_bib0032","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.9734\/BJMMR\/2014\/8393","article-title":"Mathematical model of colorectal cancer with monoclonal antibody treatments","volume":"4","author":"dePillis","year":"2014","journal-title":"Br. J. Med. Med. Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0033","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-016-0710-4","article-title":"The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer","volume":"16","author":"Dermitzakis","year":"2016","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0034","doi-asserted-by":"crossref","first-page":"063","DOI":"10.4103\/2278-330X.181629","article-title":"Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin","volume":"05","author":"Dessai","year":"2016","journal-title":"South Asian J. Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0035","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jinorgbio.2007.06.018","article-title":"Modification of carboplatin by Jurkat cells","volume":"101","author":"Di Pasqua","year":"2007","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jtbi.2026.112396_bib0036","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0301-2115(02)00234-8","article-title":"Renal impairment in patients with ovarian cancer","volume":"106","author":"Donadio","year":"2003","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0037","first-page":"1320","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"CancerSpectrum Knowl. Environ."},{"key":"10.1016\/j.jtbi.2026.112396_bib0038","doi-asserted-by":"crossref","first-page":"viii7","DOI":"10.1093\/annonc\/mdi961","article-title":"2004 Consensus statements on the management of ovarian cancer: final document of the 3rd international gynecologic cancer intergroup ovarian cancer consensus conference (GCIG OCCC 2004)","volume":"16","author":"du Bois","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0039","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003088-199733030-00002","article-title":"Clinical pharmacokinetics and dose optimisation of carboplatin","volume":"33","author":"Duffull","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jtbi.2026.112396_bib0040","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.14694\/EdBook_AM.2015.35.e311","article-title":"Epithelial ovarian cancer in older women: defining the best management approach","author":"Duska","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.jtbi.2026.112396_bib0041","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int. J. Gynecologic Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0042","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaut.2009.09.012","article-title":"Alternatively activated macrophages in infection and autoimmunity","volume":"33","author":"Fairweather","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtbi.2026.112396_bib0043","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtbi.2026.112396_bib0044","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2567.2001.01204.x","article-title":"In vivo maturation and migration of dendritic cells","volume":"102","author":"Flores-Romo","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.jtbi.2026.112396_bib0045","doi-asserted-by":"crossref","DOI":"10.1007\/BF00205575","article-title":"A phase I trial of recombinant gamma interferon in patients with cancer","volume":"20","author":"Foon","year":"1985","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jtbi.2026.112396_bib0046","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1158\/0008-5472.CAN-11-0950","article-title":"Human tumor cells killed by anthracyclines induce a tumor-specific immune response","volume":"71","author":"Fucikova","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0047","series-title":"Transforming Growth Factor Beta (TGF-\u03b2) Activity in Immuno-Oncology Studies","first-page":"129\u2014172","author":"Gallo-Oller","year":"2020"},{"key":"10.1016\/j.jtbi.2026.112396_bib0048","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jcyt.2013.05.022","article-title":"Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model","volume":"15","author":"Geller","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtbi.2026.112396_bib0049","first-page":"2875","article-title":"Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity","volume":"29","author":"Giuntoli","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-023-01216-z","article-title":"Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis","volume":"16","author":"Gong","year":"2023","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0051","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy","volume":"18","author":"Gong","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0052","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s40265-014-0221-9","article-title":"First-line and maintenance therapy for ovarian cancer: current status and future directions","volume":"74","author":"Gonz\u00e1lez-Mart\u00edn","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jtbi.2026.112396_bib0053","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.160.7.3188","article-title":"Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells","volume":"160","author":"Groux","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0054","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10147-001-8027-7","article-title":"Optimal doses of paclitaxel and carboplatin combination chemotherapy for ovarian cancer: a phase I modified continual reassessment method study","volume":"6","author":"Gynecologic Oncology Group (Tokai G","year":"2001","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0055","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1080\/21645515.2017.1327107","article-title":"Transforming growth factor-\u03b2: a therapeutic target for cancer","volume":"13","author":"Haque","year":"2017","journal-title":"Hum. Vaccines; Immunother."},{"key":"10.1016\/j.jtbi.2026.112396_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2025.112231","article-title":"Optimisation of neoadjuvant pembrolizumab therapy for locally advanced MSI-H\/dMMR colorectal cancer using data-driven delay integro-differential equations","author":"Hawi","year":"2025","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0057","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/4772","article-title":"Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans","volume":"5","author":"Hellerstein","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jtbi.2026.112396_bib0058","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: a double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jtbi.2026.112396_bib0059","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.mehy.2013.01.027","article-title":"The relationship between tumor size and stage in early versus advanced ovarian cancer","volume":"80","author":"Horvath","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jtbi.2026.112396_bib0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-9236(97)90065-5","article-title":"Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers*","volume":"62","author":"Huhn","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jtbi.2026.112396_bib0061","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1084\/jem.20051044","article-title":"IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508","volume":"202","author":"Hwang","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtbi.2026.112396_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0063","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.4049\/jimmunol.165.9.5017","article-title":"Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation","volume":"165","author":"Jelley-Gibbs","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0064","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-9255-7-37","article-title":"Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity","volume":"7","author":"Jensen","year":"2010","journal-title":"J. Inflamm."},{"key":"10.1016\/j.jtbi.2026.112396_bib0065","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0066","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/87720","article-title":"Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in na\u00efve cells","volume":"2","author":"Kaech","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02987","article-title":"Regulation of effector and memory CD8 t cell differentiation by IL-2\u2014A balancing act","volume":"9","author":"Kalia","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0068","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood.V100.5.1734.h81702001734_1734_1741","article-title":"Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs","volume":"100","author":"Kamath","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtbi.2026.112396_bib0069","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1470-2045(13)70363-2","article-title":"Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial","volume":"14","author":"Katsumata","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0070","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(09)61157-0","article-title":"Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial","volume":"374","author":"Katsumata","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jtbi.2026.112396_bib0071","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jtbi.2026.112396_bib0072","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-065X.2008.00616.x","article-title":"Multiple roles for CD4+ T cells in anti-tumor immune responses","volume":"222","author":"Kennedy","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jtbi.2026.112396_bib0073","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02503-9","article-title":"The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells","volume":"11","author":"Khing","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtbi.2026.112396_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3802\/kjgoc.1996.7.1.1","article-title":"Significance of interleukin-2(IL-2), interleukin-6(IL-6), and tumor necrosis factor-a(TNF-a) in the ascites of ovarian cancer","volume":"7","author":"Kim","year":"1996","journal-title":"Korean J. Gynecologic Oncol. Colposcopy"},{"key":"10.1016\/j.jtbi.2026.112396_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jtbi.2006.02.001","article-title":"Mathematical modeling of ovarian cancer treatments: sequencing of surgery and chemotherapy","volume":"242","author":"Kohandel","year":"2006","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0076","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jtbi.2018.11.018","article-title":"Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs","volume":"462","author":"Lai","year":"2019","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0077","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","article-title":"Regulation of T cell immunity by dendritic cells","volume":"106","author":"Lanzavecchia","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jtbi.2026.112396_bib0078","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0079","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3390\/cancers14122885","article-title":"Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review","volume":"14","author":"Liberto","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jtbi.2026.112396_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1087620","article-title":"The role of interferons in ovarian cancer progression: Hinderer or promoter?","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0081","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.134.1.157","article-title":"In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2","volume":"134","author":"Lotze","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0082","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.4049\/jimmunol.135.4.2865","article-title":"In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2","volume":"135","author":"Lotze","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0083","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jtbi.2014.02.028","article-title":"A mathematical model for pancreatic cancer growth and treatments","volume":"351","author":"Louzoun","year":"2014","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0084","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4049\/jimmunol.2001310","article-title":"IFN-\u03b3 drives human monocyte differentiation into highly proinflammatory macrophages that resemble a phenotype relevant to psoriasis","volume":"207","author":"Luque-Martin","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0085","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.12688\/f1000research.7010.1","article-title":"Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells","volume":"4","author":"Ma","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.jtbi.2026.112396_bib0086","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0638-4","article-title":"An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer","volume":"17","author":"Maley","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0087","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jtbi.2026.112396_bib0088","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.448","article-title":"Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma","volume":"5","author":"McCabe","year":"2014","journal-title":"Cell Death; Dis."},{"key":"10.1016\/j.jtbi.2026.112396_bib0089","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2026.112396_bib0090","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bjc.6601494","article-title":"Primary ovarian cancer chemotherapy: current standards of care","volume":"89","author":"McGuire","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0091","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1073\/pnas.1103782108","article-title":"CD4+ CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis","volume":"108","author":"McNally","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtbi.2026.112396_bib0092","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 macrophages: oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0093","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.semcancer.2022.03.004","article-title":"Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment","volume":"86","author":"Monavarian","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0094","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/eji.1830270105","article-title":"Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step","volume":"27","author":"Morel","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0095","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0096","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.jtbi.2026.112396_bib0097","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1200\/JCO.2000.18.17.3084","article-title":"Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer","volume":"18","author":"Neijt","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0098","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.820128","article-title":"Neoadjuvant treatment in ovarian cancer: new perspectives, new challenges","volume":"12","author":"Nikolaidi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0099","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-3083.2009.02350.x","article-title":"Production of cytokines during interaction of peripheral blood mononuclear cells with autologous ovarian cancer cells or benign ovarian tumour cells","volume":"71","author":"Nowak","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0100","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s12032-010-9512-5","article-title":"Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer","volume":"28","author":"Nurgalieva","year":"2010","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.jtbi.2026.112396_bib0101","first-page":"115","article-title":"Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge","volume":"12","author":"Oliver","year":"1993","journal-title":"Lymphokine Cytokine Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0102","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.05.017","volume":"64","author":"Onda","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0103","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1172\/JCI23215","article-title":"IL-10\u2013Producing and naturally occurring CD4+ tregs: limiting collateral damage","volume":"114","author":"O\u2019Garra","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jtbi.2026.112396_bib0104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.imlet.2004.05.003","article-title":"Interferon-\u03b3 is an autocrine mediator for dendritic cell maturation","volume":"94","author":"Pan","year":"2004","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jtbi.2026.112396_bib0105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1800618115","article-title":"T reg cells limit IFN-\u03b3 production to control macrophage accrual and phenotype during skeletal muscle regeneration","volume":"115","author":"Panduro","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtbi.2026.112396_bib0106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0025-5564(97)00077-1","article-title":"A mathematical model of breast and ovarian cancer treated with paclitaxel","volume":"146","author":"Panetta","year":"1997","journal-title":"Math. Biosci."},{"key":"10.1016\/j.jtbi.2026.112396_bib0107","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrclinonc.2010.82","article-title":"Metronomic chemotherapy: new rationale for new directions","volume":"7","author":"Pasquier","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0108","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtbi.2026.112396_bib0109","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results","volume":"92","author":"Piccart","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jtbi.2026.112396_bib0110","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.critrevonc.2007.12.005","article-title":"A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer","volume":"66","author":"Pignata","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0111","doi-asserted-by":"crossref","first-page":"viii51","DOI":"10.1093\/annonc\/mdx441","article-title":"Treatment of recurrent ovarian cancer","volume":"28","author":"Pignata","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0112","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1470-2045(14)70049-X","article-title":"Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial","volume":"15","author":"Pignata","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0113","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.drup.2012.10.003","article-title":"Understanding resistance to combination chemotherapy","volume":"15","author":"Pritchard","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.jtbi.2026.112396_bib0114","first-page":"122","article-title":"Expression of il-10 in human normal and cancerous ovarian tissues and cells","volume":"21","author":"Rabinovich","year":"2010","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.jtbi.2026.112396_bib0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cpt.2024.04.004","article-title":"Cardiotoxicity in platinum-based chemotherapy: mechanisms, manifestations, and management","volume":"3","author":"Rachma","year":"2025","journal-title":"Cancer Pathogen. Ther."},{"key":"10.1016\/j.jtbi.2026.112396_bib0116","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jtbi.2026.112396_bib0117","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4049\/jimmunol.155.2.609","article-title":"Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells","volume":"155","author":"Rich","year":"1995","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.jtbi.2026.112396_bib0118","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1535-7163.MCT-20-0412","article-title":"Neutralization of TGF-\u03b2 improves tumor immunity and reduces tumor progression in ovarian carcinoma","volume":"20","author":"Roane","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jtbi.2026.112396_bib0119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ygyno.2020.10.019","article-title":"A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers","volume":"160","author":"Rubinstein","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0120","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1126\/science.1191996","article-title":"Stability of the regulatory T cell lineage in vivo","volume":"329","author":"Rubtsov","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jtbi.2026.112396_bib0121","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.4049\/jimmunol.165.9.4910","article-title":"Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes","volume":"165","author":"Ruedl","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0122","article-title":"Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer","volume":"8","author":"R\u00e5destad","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtbi.2026.112396_bib0123","first-page":"567","article-title":"Recombinant human tnf-alpha: preclinical studies and results from early clinical trials","volume":"56","author":"Saks","year":"1992","journal-title":"Immunol. Ser."},{"key":"10.1016\/j.jtbi.2026.112396_bib0124","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2020.07.022","article-title":"FoxP3+ T regulatory cells in cancer: prognostic biomarkers and therapeutic targets","volume":"490","author":"Saleh","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jtbi.2026.112396_bib0125","first-page":"445","article-title":"An alternative way to compute fourier amplitude sensitivity test (FAST)","volume":"26","author":"Saltelli","year":"1998","journal-title":"Comput. Stat. &amp: Data Anal."},{"key":"10.1016\/j.jtbi.2026.112396_bib0126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00401706.1999.10485594","article-title":"A quantitative model-independent method for global sensitivity analysis of model output","volume":"41","author":"Saltelli","year":"1999","journal-title":"Technometrics"},{"key":"10.1016\/j.jtbi.2026.112396_bib0127","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/pharmaceutics13071016","article-title":"The role of mathematical models in immuno-oncology: challenges and future perspectives","volume":"13","author":"Sancho-Araiz","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtbi.2026.112396_bib0128","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.3390\/cancers14092220","article-title":"Tumor-associated macrophages and ovarian cancer: implications for therapy","volume":"14","author":"Schweer","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jtbi.2026.112396_bib0129","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308511120","article-title":"The total mass, number, and distribution of immune cells in the human body","volume":"120","author":"Sender","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jtbi.2026.112396_bib0130","doi-asserted-by":"crossref","first-page":"12163","DOI":"10.18632\/oncotarget.7512","article-title":"Human na\u00efve regulatory T-cells feature high steady-state turnover and are maintained by IL-7","volume":"7","author":"Silva","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtbi.2026.112396_bib0131","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1126\/science.3131876","article-title":"Interleukin-2: inception, impact, and implications","volume":"240","author":"Smith","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.jtbi.2026.112396_bib0132","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s11538-017-0277-2","article-title":"Methods of model reduction for large-scale biological systems: a survey of current methods and trends","volume":"79","author":"Snowden","year":"2017","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0133","first-page":"407","article-title":"Sensitivity analysis for non-linear mathematical models","volume":"1","author":"Sobol\u2019","year":"1993","journal-title":"Math. Modeling Comput. Exp."},{"key":"10.1016\/j.jtbi.2026.112396_bib0134","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1590\/S1984-82502014000400004","article-title":"Carboplatin: molecular mechanisms of action associated with chemoresistance","volume":"50","author":"Sousa","year":"2014","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.jtbi.2026.112396_bib0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.23.01771","article-title":"Treatment approaches for platinum-resistant ovarian cancer","volume":"42","author":"St Laurent","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0136","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28655-4","article-title":"Comprehensive evaluation of deconvolution methods for human brain gene expression","volume":"13","author":"Sutton","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtbi.2026.112396_bib0137","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1084\/jem.20082553","article-title":"Self\u2013class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels","volume":"206","author":"Takada","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jtbi.2026.112396_bib0138","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/intimm\/dxw025","article-title":"Roles of regulatory T cells in cancer immunity","volume":"28","author":"Takeuchi","year":"2016","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0139","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ijgc-00009577-200305000-00006","article-title":"Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma?","volume":"13","author":"Tangjitgamol","year":"2003","journal-title":"Int. J. Gynecological Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0140","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.167.10.5574","article-title":"Regulation of IFN-\u03b3 signaling is essential for the cytotoxic activity of CD8+ t cells","volume":"167","author":"Tau","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0141","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1023\/A:1008219618331","article-title":"Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancer","volume":"8","author":"ten Bokkel Huinink","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0142","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-\u03b2 directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtbi.2026.112396_bib0143","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41423-018-0005-3","article-title":"Chemokine and chemotactic signals in dendritic cell migration","volume":"15","author":"Tiberio","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/318481","article-title":"TGF-\u03b2: an important mediator of allergic disease and a molecule with dual activity in cancer development","volume":"2014","author":"Tirado-Rodriguez","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0145","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jtbi.2026.112396_bib0146","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.4049\/jimmunol.0903918","article-title":"Regulatory t cells inhibit t cell proliferation and decrease demyelination in mice chronically infected with a coronavirus","volume":"184","author":"Trandem","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0147","series-title":"Biology of Natural Killer Cells","first-page":"187","author":"Trinchieri","year":"1989"},{"key":"10.1016\/j.jtbi.2026.112396_bib0148","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0149","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005968","article-title":"Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma","volume":"11","author":"Truxova","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0150","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79342","article-title":"Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2","volume":"12","author":"Tsyklauri","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jtbi.2026.112396_bib0151","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/gast.1997.v113.pm9247454","article-title":"Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn\u2019s disease. Crohn\u2019s disease study group","volume":"113","author":"van Deventer","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtbi.2026.112396_bib0152","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S1470-2045(18)30566-7","article-title":"Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials","volume":"19","author":"Vergote","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0153","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S1470-2045(22)00139-5","article-title":"Clinical research in ovarian cancer: consensus recommendations from the gynecologic cancer InterGroup","volume":"23","author":"Vergote","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0154","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtbi.2026.112396_bib0155","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aad1884","article-title":"Tgf-\u03b2 inhibits the activation and functions of nk cells by repressing the mtor pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci. Signal"},{"key":"10.1016\/j.jtbi.2026.112396_bib0156","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0277-5379(89)90208-3","article-title":"A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives","volume":"25","author":"Voest","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0157","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1172\/JCI28941","article-title":"Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo","volume":"116","author":"Vukmanovic-Stejic","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jtbi.2026.112396_bib0158","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells: \u201cl\u2019union fait la force\u201d","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtbi.2026.112396_bib0159","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jtbi.2026.112396_bib0160","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood-2006-01-0177","article-title":"Regulatory T-cell compartmentalization and trafficking","volume":"108","author":"Wei","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtbi.2026.112396_bib0161","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0002-9378(92)91658-W","article-title":"Meta-analysis of surgery in advanced ovarian carcinoma: ismaximum cytoreductive surgery an independent determinant of prognosis?","volume":"166","author":"William Hunter","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0162","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.4049\/jimmunol.1302379","article-title":"IFN-\u03b3 primes macrophage activation by increasing phosphatase and tensin homolog via downregulation of miR-3473b","volume":"193","author":"Wu","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0163","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jtbi.2026.112396_bib0164","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0394632015593228","article-title":"TNF-A mediated inflammatory macrophage polarization contributes to the pathogenesis of steroid-induced osteonecrosis in mice","volume":"28","author":"Wu","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0165","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.658","article-title":"Macrophage plasticity: signaling pathways, tissue repair, and regeneration","volume":"5","author":"Yan","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.jtbi.2026.112396_bib0166","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-024-01943-5","article-title":"Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer","author":"Yeh","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0167","doi-asserted-by":"crossref","first-page":"11621","DOI":"10.1074\/jbc.M113.449942","article-title":"Real-time kinetics of high-mobility group box 1 (HMGB1) oxidation in extracellular fluids studied by in situ protein NMR spectroscopy","volume":"288","author":"Zandarashvili","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jtbi.2026.112396_bib0168","unstructured":"Zealand, M. N., 2023. Paclitaxel ebewe concentrate for solution for infusion. https:\/\/www.medsafe.govt.nz\/profs\/datasheet\/p\/PaclitaxelEbeweinj.pdf."},{"key":"10.1016\/j.jtbi.2026.112396_bib0169","doi-asserted-by":"crossref","first-page":"52294","DOI":"10.18632\/oncotarget.10561","article-title":"TGF-\u03b2 induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtbi.2026.112396_bib0170","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.3390\/cancers13112801","article-title":"Engineering calreticulin-targeting monobodies to detect immunogenic cell death in cancer chemotherapy","volume":"13","author":"Zhang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jtbi.2026.112396_bib0171","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2567.2007.02573.x","article-title":"In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection","volume":"121","author":"Zhang","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.jtbi.2026.112396_bib0172","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.178.4.2018","article-title":"IL-2 is essential for TGF-\u03b2 to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells","volume":"178","author":"Zheng","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jtbi.2026.112396_bib0173","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/147323000703500302","article-title":"The expression of interleukin-10 in patients with primary ovarian epithelial carcinoma and in ovarian carcinoma cell lines","volume":"35","author":"Zhou","year":"2007","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jtbi.2026.112396_bib0174","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00025","article-title":"Regulation of NK cell activation and effector functions by the IL-12 family of cytokines: the case of IL-27","volume":"8","author":"Zwirner","year":"2017","journal-title":"Front. Immunol."}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519326000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022519326000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:31:15Z","timestamp":1777422675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022519326000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":174,"alternative-id":["S0022519326000214"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2026.112396","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimising chemotherapy for advanced high-grade serous ovarian cancer via delay-differential equations","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2026.112396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"112396"}}